Results 61 to 70 of about 4,977 (176)

Topical timolol for small infantile hemangioma: a new therapy option

The Turkish Journal of Pediatrics, 2012
The main characteristic of infantile hemangioma is that it grows rapidly after birth and mostly regresses spontaneously. It is a common practice for only a small part of the hemangioma to be treated, as they can be extremely disfiguring and ...
Anne Weissenstein, Alexandra Straeter, Gloria Villalon, Stefan Bittmann   +3 more
doaj  

Kaposiform hemangioendothelioma: Diagnosis and treatment

Pediatric Investigation, Volume 10, Issue 3, Page 269-280, June 2026.
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Yi Tian, Yuanyuan Tian, Li Wei, Zigang Xu, Li Li, Lin Ma   +5 more
wiley   +1 more source

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma

eLife, 2019
Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma. Despite the clinical benefit of propranolol therapy in hemangioma, the mechanistic understanding of what drives this outcome is limited ...
Jeroen Overman, Frank Fontaine, Jill Wylie-Sears, Mehdi Moustaqil, Lan Huang, Marie Meurer, Ivy Kim Chiang, Emmanuelle Lesieur, Jatin Patel, Johannes Zuegg, Eddy Pasquier, Emma Sierecki, Yann Gambin, Mohamed Hamdan, Kiarash Khosrotehrani, Gregor Andelfinger, Joyce Bischoff, Mathias Francois   +17 more
doaj   +1 more source

Experience with the successful use of topical beta-adrenoblockers in the treatment of infantile hemangiomas: a clinical case and review of the literature

Лечащий Врач
Background. Infantile (infantile) hemangiomas are benign vascular tumors found predominantly in the pediatric population. Its presence can lead not only to aesthetic discomfort of the child, but also to gross functional disorders.
R. V. Saranyuk, T. A. Gosteva
doaj   +1 more source

Propranolol Treatment in the Management of Infantile Hemangioma in Erbil, Iraq [PDF]

Iranian Journal of Neonatology
Background: Infantile hemangioma is a common benign vascular tumor that affects up to 10% of infants. Propranolol, a beta-blocker, has been used as a promising treatment for infantile hemangioma, but its effectiveness remains controversial.
Wesam Boya Kaka, Siamand Salim, Jalal Fattah   +2 more
doaj   +1 more source

Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants

Pediatrics and Neonatology, 2012
Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years.
Teng-Chin Hsu, Jiaan-Der Wang, Chao-Huei Chen, Te-Kau Chang, Teh-Ming Wang, Chia-Man Chou, Heng-Kuei Lin   +6 more
doaj   +1 more source

Hemangiomas infantiles

Acta Pediátrica de México, 2017
Las lesiones vasculares en lactantes y niños se clasifican principalmente en dos grupos: tumores y malformaciones vasculares. Los hemangiomas infantiles se encuentran dentro del grupo de tumores benignos junto con otros como el granuloma piógeno, hemangioendotelioma kaposiforme y el hemangioma en penacho. Sin embargo, los hemangiomas infantiles son los
Carolina Hernández-Zepeda, María Teresa García- Romero   +1 more
openaire   +3 more sources

Propranolol and Neurodevelopment in Infantile Hemangioma: Reassuring Signals From Real‐World Data

JEADV Clinical Practice, Volume 5, Issue 2, Page 363-364, June 2026.
Alain Taïeb
wiley   +1 more source

Editor's Picks June 2026

JEADV Clinical Practice, Volume 5, Issue 2, Page 357-360, June 2026.
Antonio Torrelo
wiley   +1 more source

Itraconazole Oral Solution for Infantile Complicated Hemangioma with Double Lesions on the Skin and One Inside the Liver

Clinical, Cosmetic and Investigational Dermatology
Xian He,1,2 Xin Ran,1 Dan Liang,2 Hongxia Fan,3 Yuping Ran1 1Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Department of Allergy, Chengdu First People’s Hospital, Chengdu, People’s ...
He X, Ran X, Liang D, Fan H, Ran Y
doaj